Moteur de recherche d’entreprises européennes
Financement de l’UE (5 457 480 €) : Évaluation de la technologie de la santé mobile dans le domaine du VIH pour améliorer l’autonomisation et l’utilisation des soins de santé : recherche et … Hor01/05/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Évaluation de la technologie de la santé mobile dans le domaine du VIH pour améliorer l’autonomisation et l’utilisation des soins de santé : recherche et innovation pour générer des données probantes en faveur de soins personnalisés
EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers EATG, the European HIV patient organisation, will provide a direct and deep interaction with representative patients and clinicians from 5 EU countries. The platform and interfaces will be validated in a large study of 3900 patients using a tailored HTA process, MAST, specifically developed for the assessment of mHealth solutions including translatability as a key factor. Based on prior work showing a high uptake rate and use of mHealth in HIV patient populations, EmERGE aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, estimated at 6000 saved per year within this study alone. Patient reported outcomes will be agreed and used in the assessment and development of the system which also aims to increase adherence and enable frailty to be reported using mHealth technology. Innovation will be given priority from the beginning by developing new business models of care provision, targeting key stakeholders in the EU health provider sector, including policymakers and clinicians, while eliciting demand from patients to highlight and initiate the widespread implementation and compensation of mHealth solutions within the timeframe of the project. Guidelines and policy briefs will be produced to evidence the benefits and disseminate the lessons learned to support the uptake of mHealth for self-management of other chronic diseases.
| 870 878 € | |
| CENTRO HOSPITALAR DE LISBOA CENTRAL ΕΠΕ | 338 062 € |
| EUROPEAN AIDS TREATMENT GROUP e. V. | 483 429 € |
| Emerge Mhealth Ltd. | 212 869 € |
| Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i Sunyer | 724 756 € |
| Hospital Clinic de Barcelona | 0,00 € |
| Instituut Voor Tropische Geneeskunde | 413 552 € |
| Kite Innovation (Europe) Ltd. | 118 601 € |
| Klinika ZA Infektivne Bolesti DR. Fran Mihaljevic | 310 143 € |
| Mhealth Futures Ltd. | 69 422 € |
| Modus Research and Innovation Ltd. | 191 405 € |
| Npms-HHC CIC | 466 425 € |
| Podmedics Ltd. | 198 473 € |
| 82 775 € | |
| Universidad Politecnica de Madrid | 403 519 € |
| University of Brighton | 573 171 € |
https://cordis.europa.eu/project/id/643736
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Brighton and Sussex University Hospitals NHS Trust - Financement de l’UE (5 457 480 €) : Évaluation de la technologie de la santé mobile dans le domaine du VIH pour améliorer l’autonomisation et l’utilisation des soins de santé : recherche et innovation pour générer des données probantes en faveur de soins personnalisés"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
